期刊
POSTGRADUATE MEDICINE
卷 122, 期 1, 页码 139-143出版社
TAYLOR & FRANCIS LTD
DOI: 10.3810/pgm.2010.01.2107
关键词
rosacea; inflammatory disease; pharmacotherapy; dermatological conditions
Rosacea is a common chronic inflammatory disease of the skin and is associated with a number of etiological causes and inciting factors. It is characterized by erythematous charges of the facial skin, and commonly presents with papules, pustules, or telangiectasias The 4 subtypes of rosacea are categorized according to secondary symptoms, such as pain, erythema, dryness, and edema. A number of therapies are available to treat rosacea, some of which can be used in combination. The mainstays of therapy are topical metronidazole, topical azelaic acid, and oral tetracyclines. Other pharmacotherapeutic interventions have been shown to improve the signs and symptoms Of rosacea, although many of these have not yet received approval by the US Food and Drug Administration for this indication.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据